Go Pro
→ Your book is inside (From Profits Run) (Ad)tc pixel Free AFIB Stock Alerts

Acutus Medical (AFIB) Competitors

Acutus Medical logo
Compare

AFIB vs. TTOO, UTRS, MOTS, DRTSW, and BDMDW

Should you buy Acutus Medical stock or one of its competitors? Acutus Medical's main competitors and comparable companies include T2 Biosystems (TTOO), Minerva Surgical (UTRS), Motus GI (MOTS), Alpha Tau Medical (DRTSW), and Baird Medical Investment (BDMDW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Acutus Medical compare to T2 Biosystems?

T2 Biosystems (NASDAQ:TTOO) and Acutus Medical (NASDAQ:AFIB) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership and analyst recommendations.

T2 Biosystems has higher revenue and earnings than Acutus Medical. T2 Biosystems is trading at a lower price-to-earnings ratio than Acutus Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
T2 Biosystems$7.68M0.00-$50.08M-$3.89N/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

Acutus Medical has a net margin of -272.74% compared to T2 Biosystems' net margin of -563.16%. T2 Biosystems' return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
T2 Biosystems-563.16% N/A -174.06%
Acutus Medical -272.74%-311.64%-11.57%

23.2% of T2 Biosystems shares are held by institutional investors. Comparatively, 56.9% of Acutus Medical shares are held by institutional investors. 0.0% of T2 Biosystems shares are held by company insiders. Comparatively, 5.2% of Acutus Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, T2 Biosystems' average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
T2 Biosystems Neutral
Acutus Medical Neutral

T2 Biosystems has a beta of 7.9, suggesting that its stock price is 690% more volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.73, suggesting that its stock price is 473% more volatile than the broader market.

Summary

T2 Biosystems and Acutus Medical tied by winning 5 of the 10 factors compared between the two stocks.

How does Acutus Medical compare to Minerva Surgical?

Minerva Surgical (NASDAQ:UTRS) and Acutus Medical (NASDAQ:AFIB) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, earnings, valuation and risk.

Minerva Surgical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Minerva Surgical's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

56.9% of Acutus Medical shares are held by institutional investors. 8.5% of Minerva Surgical shares are held by company insiders. Comparatively, 5.2% of Acutus Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Acutus Medical Neutral

Minerva Surgical has higher revenue and earnings than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

Minerva Surgical has a beta of 2.37, meaning that its share price is 137% more volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.73, meaning that its share price is 473% more volatile than the broader market.

Summary

Minerva Surgical beats Acutus Medical on 7 of the 10 factors compared between the two stocks.

How does Acutus Medical compare to Motus GI?

Motus GI (NASDAQ:MOTS) and Acutus Medical (NASDAQ:AFIB) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, risk, profitability, media sentiment and valuation.

Motus GI has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.73, suggesting that its stock price is 473% more volatile than the broader market.

Motus GI has higher earnings, but lower revenue than Acutus Medical. Motus GI is trading at a lower price-to-earnings ratio than Acutus Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

20.1% of Motus GI shares are held by institutional investors. Comparatively, 56.9% of Acutus Medical shares are held by institutional investors. 0.3% of Motus GI shares are held by company insiders. Comparatively, 5.2% of Acutus Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Motus GI has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Motus GI's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Acutus Medical Neutral

Summary

Motus GI and Acutus Medical tied by winning 5 of the 10 factors compared between the two stocks.

How does Acutus Medical compare to Alpha Tau Medical?

Acutus Medical (NASDAQ:AFIB) and Alpha Tau Medical (NASDAQ:DRTSW) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability and institutional ownership.

Alpha Tau Medical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Alpha Tau Medical's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
Alpha Tau Medical N/A N/A N/A

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled Alpha Tau Medical'saverage media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
Alpha Tau Medical Neutral

Alpha Tau Medical has lower revenue, but higher earnings than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

56.9% of Acutus Medical shares are held by institutional investors. 5.2% of Acutus Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Acutus Medical and Alpha Tau Medical tied by winning 3 of the 6 factors compared between the two stocks.

How does Acutus Medical compare to Baird Medical Investment?

Baird Medical Investment (NASDAQ:BDMDW) and Acutus Medical (NASDAQ:AFIB) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

56.9% of Acutus Medical shares are held by institutional investors. 5.2% of Acutus Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Baird Medical Investment has higher revenue and earnings than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baird Medical Investment$24.49MN/AN/AN/AN/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

Baird Medical Investment has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Baird Medical Investment's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Baird Medical InvestmentN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

In the previous week, Baird Medical Investment's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
Baird Medical Investment Neutral
Acutus Medical Neutral

Summary

Baird Medical Investment beats Acutus Medical on 4 of the 6 factors compared between the two stocks.

Get Acutus Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AFIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AFIB vs. The Competition

Export
MetricAcutus MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$3K$5.48B$7.15B$13.28B
Dividend YieldN/A1.81%2.54%17.33%
P/E Ratio0.0024.90275.6726.04
Price / SalesN/A67.76656.66111.00
Price / CashN/A32.2778.8752.62
Price / BookN/A5.7310.936.31
Net Income-$81.66M$152.68M$3.51B$362.16M

Acutus Medical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AFIB
Acutus Medical
N/AN/AN/AN/A$3K$7.16MN/A85
TTOO
T2 Biosystems
N/A$0.00
flat		N/A-94.5%$11K$7.68MN/A113
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69MN/A174
MOTS
Motus GI
N/A$0.00
flat		N/AN/A$1K$319KN/A15
DRTSW
Alpha Tau Medical
N/A$3.98
-0.6%		N/A+983.6%$0.00N/AN/A80

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:AFIB) was last updated on 10/4/2026 by MarketBeat.com Staff.
From Our Partners
Ray Dalio: Buy Gold. Get Paid.
Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...
Investors Alley | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Elon Warns "America Will Go Bankrupt". Trump's Plan Inside.
National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...
American Hartford Gold | Sponsoredtc pixel
How options let you do more with less capital
Would you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...
Base Camp Trading | Sponsoredtc pixel
Free Stock: Economist calls it “the world’s most important machine.”
Nvidia's most expensive chip component isn't made by Nvidia. Jeff Brown, former semiconductor executive, says ...
Brownstone Research | Sponsoredtc pixel
The case for $20,000 gold before year end
President Trump reposted a warning from precious metals expert Jim Rickards, tying the November midterms and A...
Stansberry Research | Sponsoredtc pixel
A major gold reset could be closer than people think
For 50 years, Washington has held 8,133 tonnes of gold on its books at a fraction of today's market price. One...
Reagan Gold Group | Sponsoredtc pixel